Trial NCT00994890

View at ClinicalTrials.gov 
Org. Study IDs: A4091043
Secondary IDs: SC OA SAFETY STUDY

Last trial update was posted on 2021-05-13

MeSH Interventions

Tanezumab

MeSH Conditions

Osteoarthritis Osteoarthritis, Hip Osteoarthritis, Knee

Other Conditions


Stopping Reasons

See termination reason in detailed description.

Limitations And Caveats

Due to United States FDA imposed clinical hold, enrollment was stopped and study was terminated prematurely. Due to this, injection-site reaction data were not collected beyond Week 40 and NIS data were not collected beyond Week 48.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID